$SMAR
Smartsheet Inc

2023 Q2 Form 10-Q Financial Statement

#000136656123000062 Filed on June 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $219.9M $212.3M
YoY Change 30.64% 34.91%
Cost Of Revenue $45.88M $44.71M
YoY Change 23.48% 35.41%
Gross Profit $174.0M $167.6M
YoY Change 32.67% 34.78%
Gross Profit Margin 79.13% 78.94%
Selling, General & Admin $149.9M $153.7M
YoY Change 1.01% 33.3%
% of Gross Profit 86.16% 91.67%
Research & Development $56.19M $58.38M
YoY Change 6.99% 19.78%
% of Gross Profit 32.29% 34.83%
Depreciation & Amortization $6.410M $6.380M
YoY Change 5.46% -54.75%
% of Gross Profit 3.68% 3.81%
Operating Expenses $206.1M $212.0M
YoY Change 2.57% 20.13%
Operating Profit -$32.12M -$44.42M
YoY Change -53.99% -14.82%
Interest Expense $5.217M $3.729M
YoY Change 1244.59% 28584.62%
% of Operating Profit
Other Income/Expense, Net -$536.0K -$285.0K
YoY Change -35.27% -69.19%
Pretax Income -$27.43M -$40.97M
YoY Change -60.94% -22.77%
Income Tax $2.400M $1.758M
% Of Pretax Income
Net Earnings -$29.87M -$42.73M
YoY Change -57.61% -19.58%
Net Earnings / Revenue -13.58% -20.12%
Basic Earnings Per Share -$0.23
Diluted Earnings Per Share -$0.23 -$0.33
COMMON SHARES
Basic Shares Outstanding 132.5M shares 132.5M shares
Diluted Shares Outstanding 132.5M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $489.5M $456.4M
YoY Change 9.6% 1.63%
Cash & Equivalents $294.9M $223.2M
Short-Term Investments $194.6M $233.2M
Other Short-Term Assets $11.36M $55.06M
YoY Change -75.31% 60.11%
Inventory
Prepaid Expenses $56.67M $45.88M
Receivables $152.1M $198.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $709.7M $710.1M
YoY Change 15.93% 11.89%
LONG-TERM ASSETS
Property, Plant & Equipment $39.16M $93.67M
YoY Change 3.64% 154.3%
Goodwill $141.5M $142.4M
YoY Change 12.67% 13.38%
Intangibles $36.10M $39.07M
YoY Change -13.25% -11.4%
Long-Term Investments
YoY Change
Other Assets $3.135M $125.0M
YoY Change 7.0% 3812.49%
Total Long-Term Assets $400.3M $400.1M
YoY Change 8.24% 8.66%
TOTAL ASSETS
Total Short-Term Assets $709.7M $710.1M
Total Long-Term Assets $400.3M $400.1M
Total Assets $1.110B $1.110B
YoY Change 13.03% 10.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.727M $2.125M
YoY Change -76.55% 41.1%
Accrued Expenses $101.2M $115.0M
YoY Change 12.37% 10.96%
Deferred Revenue $453.8M $457.5M
YoY Change 31.68% 37.69%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $556.7M $574.7M
YoY Change 25.94% 31.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $337.0K $49.89M
YoY Change -99.43%
Total Long-Term Liabilities $337.0K $49.89M
YoY Change -99.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $556.7M $574.7M
Total Long-Term Liabilities $337.0K $49.89M
Total Liabilities $602.0M $624.6M
YoY Change 20.16% 25.4%
SHAREHOLDERS EQUITY
Retained Earnings -$788.0M -$758.2M
YoY Change 28.56% 39.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $508.0M $485.7M
YoY Change
Total Liabilities & Shareholders Equity $1.110B $1.110B
YoY Change 13.03% 10.71%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$29.87M -$42.73M
YoY Change -57.61% -19.58%
Depreciation, Depletion And Amortization $6.410M $6.380M
YoY Change 5.46% -54.75%
Cash From Operating Activities $34.57M $20.19M
YoY Change -784.17% -13384.87%
INVESTING ACTIVITIES
Capital Expenditures $853.0K $3.796M
YoY Change -49.56% -244.77%
Acquisitions
YoY Change
Other Investing Activities $34.89M $9.337M
YoY Change -116.89%
Cash From Investing Activities $31.64M $5.541M
YoY Change -115.03% -311.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.775M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.694M 2.680M
YoY Change -16.36% -79.56%
NET CHANGE
Cash From Operating Activities $34.57M 20.19M
Cash From Investing Activities $31.64M 5.541M
Cash From Financing Activities $5.694M 2.680M
Net Change In Cash $71.80M 28.41M
YoY Change -134.25% 174.82%
FREE CASH FLOW
Cash From Operating Activities $34.57M $20.19M
Capital Expenditures $853.0K $3.796M
Free Cash Flow $33.72M $16.40M
YoY Change -599.97% 563.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001366561
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
001-38464
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Smartsheet Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2954357
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
500 108th Ave NE, Suite 200
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Bellevue,
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98004
CY2023Q2 dei City Area Code
CityAreaCode
(844)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
324-2360
CY2023Q2 dei Security12b Title
Security12bTitle
Class A common stock, no par value per share
CY2023Q2 dei Trading Symbol
TradingSymbol
SMAR
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
133608334 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219886000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168310000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45881000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
37158000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
174005000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
131152000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56190000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52519000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
114952000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
115391000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34978000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33044000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
206120000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
200954000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-32115000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-69802000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5217000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
388000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-536000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-828000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27434000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70242000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2436000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
215000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29870000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-70457000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132542000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132542000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128519000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128519000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29870000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-70457000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
189000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-342000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-646000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-457000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-342000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30327000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70799000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
294946000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
223156000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
194593000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
233225000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5586000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6285000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
152104000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
198643000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68025000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
55063000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
709668000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
710087000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
189000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
197000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
129058000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
121785000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39162000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39395000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51123000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54278000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36097000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39069000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
141518000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
142415000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3135000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2983000 usd
CY2023Q2 us-gaap Assets
Assets
1109950000 usd
CY2023Q1 us-gaap Assets
Assets
1110209000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1727000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2125000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53106000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
68347000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28783000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27437000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19299000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19220000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
453831000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
457534000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
556746000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
574663000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43372000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47564000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1530000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2195000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
337000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
129000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
601985000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
624551000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1296364000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1243730000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-356000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
101000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-788043000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-758173000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
507965000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
485658000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1109950000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1110209000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
485658000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
589000 usd
CY2023Q2 smar Share Based Payment Arrangement Taxes Paid For Tax Withholding Obligation
ShareBasedPaymentArrangementTaxesPaidForTaxWithholdingObligation
621000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52666000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-457000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29870000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
507965000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
504779000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3714000 usd
CY2022Q2 smar Share Based Payment Arrangement Taxes Paid For Tax Withholding Obligation
ShareBasedPaymentArrangementTaxesPaidForTaxWithholdingObligation
1366000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44648000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-342000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-70457000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
480976000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29870000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-70457000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
51779000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
43900000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
6410000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
6078000 usd
CY2023Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2028000 usd
CY2022Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
49000 usd
CY2023Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
11429000 usd
CY2022Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
13077000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-381000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-589000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3155000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3899000 usd
CY2023Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
872000 usd
CY2022Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45746000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31489000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6981000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13103000 usd
CY2023Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
267000 usd
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-32000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-246000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5688000 usd
CY2023Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1581000 usd
CY2022Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
5595000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-20552000 usd
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-23790000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
18701000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
15895000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4452000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11761000 usd
CY2023Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
210000 usd
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
CY2023Q2 smar Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
3895000 usd
CY2022Q2 smar Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
3867000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34571000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5053000 usd
CY2023Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
62010000 usd
CY2022Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
207274000 usd
CY2023Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
96885000 usd
CY2022Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
CY2023Q2 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
CY2022Q2 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
622000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
853000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1691000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16000 usd
CY2022Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
94000 usd
CY2023Q2 us-gaap Payments For Software
PaymentsForSoftware
2397000 usd
CY2022Q2 us-gaap Payments For Software
PaymentsForSoftware
2323000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
31641000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210572000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
532000 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1370000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
621000 usd
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1366000 usd
CY2023Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5783000 usd
CY2022Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
6804000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5694000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6808000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-108000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-821000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71798000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-209638000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223757000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
449680000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295555000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240042000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
69000 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
68000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
503000 usd
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
789000 usd
CY2023Q2 smar Share Based Compensation Capitalized Software Development Costs
ShareBasedCompensationCapitalizedSoftwareDevelopmentCosts
803000 usd
CY2022Q2 smar Share Based Compensation Capitalized Software Development Costs
ShareBasedCompensationCapitalizedSoftwareDevelopmentCosts
748000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4464000 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could differ from those estimates. The Company’s most significant estimates and judgments involve the measurement of fair values of share-based compensation award grants; determination of the amortization period for capitalized sales commission costs; and revenue recognition with respect to the allocation of transaction consideration for the Company’s offerings, among others.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed an assessment of the amortization period for deferred sales commission costs and determined that it should increase the period over which we amortize deferred commissions from three years to four years. This change in accounting estimate was effective August 1, 2022 and is being accounted for prospectively in the condensed consolidated financial statements. For the quarter ended April 30, 2023, the change in amortization period resulted in a benefit to both sales and marketing expense and net loss of approximately 2% of total revenue or $0.04 per basic and diluted share. The effect of this change in estimate is based on the carrying value of deferred commissions included in the Company’s consolidated balance sheets as of July 31, 2022 and those deferred during subsequent periods.</span></div>
CY2022Q3 smar Deferred Sales Commissions Amortization Period
DeferredSalesCommissionsAmortizationPeriod
P3Y
smar Deferred Sales Commissions Amortization Period
DeferredSalesCommissionsAmortizationPeriod
P4Y
CY2023Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of risk and significant customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, short-term investments, and accounts receivable. The Company maintains its cash accounts with financial institutions where deposits, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) limits.</span></div>
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
525800000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.92
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
129100000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
121800000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
11400000 usd
CY2022Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
13100000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P3Y
CY2022Q3 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29870000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-70457000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132542000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132542000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128519000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128519000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14280000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11785000 shares
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
437584000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
104000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
84000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
84000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
437604000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
1300000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
374381000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
60000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
229000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
374212000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
1100000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
142415000 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-897000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
141518000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66890000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
30793000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36097000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
67173000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28104000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
39069000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
36021000 usd
CY2023Q2 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
38990000 usd
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y2M12D
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8128000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9635000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7918000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5752000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3455000 usd
CY2023Q2 smar Finite Lived Intangible Assets Expected Amortization After Year Four
FiniteLivedIntangibleAssetsExpectedAmortizationAfterYearFour
1165000 usd
CY2023Q2 smar Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
36053000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51779000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43900000 usd
CY2023Q2 smar Capitalized Software Development Costs Excluded From Share Based Compensation Expense
CapitalizedSoftwareDevelopmentCostsExcludedFromShareBasedCompensationExpense
900000 usd
CY2022Q2 smar Capitalized Software Development Costs Excluded From Share Based Compensation Expense
CapitalizedSoftwareDevelopmentCostsExcludedFromShareBasedCompensationExpense
700000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2023Q2 smar Lessee Leases Renewal Term
LesseeLeasesRenewalTerm
P5Y
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3981000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
4879000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
180000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
129000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
851000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
567000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
547000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
4465000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
5575000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4720000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4652000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4464000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
14939000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
16986000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14519000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10831000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6041000 usd
CY2023Q2 smar Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
6236000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
69552000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6881000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
62671000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
1750000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
2396000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
1986000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
700000 usd
CY2023Q2 smar Lessor Operating Lease Payment To Be Received After Year Three
LessorOperatingLeasePaymentToBeReceivedAfterYearThree
0 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
6832000 usd
CY2021Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
10000000 usd
CY2023Q2 us-gaap Proceeds From Collection Of Other Receivables
ProceedsFromCollectionOfOtherReceivables
3900000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219886000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168310000 usd
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
66491000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
70613000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
56665000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
45877000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
11360000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9186000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68025000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
55063000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
294946000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
239683000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
420000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
343000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
189000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
16000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295555000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240042000 usd

Files In Submission

Name View Source Status
0001366561-23-000062-index-headers.html Edgar Link pending
0001366561-23-000062-index.html Edgar Link pending
0001366561-23-000062.txt Edgar Link pending
0001366561-23-000062-xbrl.zip Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smar-20230430.htm Edgar Link pending
smar-20230430.xsd Edgar Link pending
smar-20230430_cal.xml Edgar Link unprocessable
smar-20230430_pre.xml Edgar Link unprocessable
smar-20230430_lab.xml Edgar Link unprocessable
smar-20230430_def.xml Edgar Link unprocessable
smar-20230430_htm.xml Edgar Link completed